Page last updated: 2024-10-24

carvedilol and Liver Steatosis

carvedilol has been researched along with Liver Steatosis in 1 studies

Research Excerpts

ExcerptRelevanceReference
" In addition, factors potentially involved in hepatic ischemia-reperfusion injury, including oxidative stress (malondialdehyde and superoxide anion levels), mitochondrial damage (glutamate dehydrogenase activity), microcirculatory disorders (flow rate and vascular resistance), and adenosine triphosphate (ATP) depletion, were evaluated after reperfusion."3.76Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation. ( Alfany-Fernandez, I; Ben Abdennebi, H; Ben Mosbah, I; Boillot, O; Lojek, A; Mitjavila, MT; Parellada, PP; Peralta, C; Rimola, A; Rodés, J; Roselló-Catafau, J, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ben Mosbah, I1
Roselló-Catafau, J1
Alfany-Fernandez, I1
Rimola, A1
Parellada, PP1
Mitjavila, MT1
Lojek, A1
Ben Abdennebi, H1
Boillot, O1
Rodés, J1
Peralta, C1

Other Studies

1 other study available for carvedilol and Liver Steatosis

ArticleYear
Addition of carvedilol to University Wisconsin solution improves rat steatotic and nonsteatotic liver preservation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2010, Volume: 16, Issue:2

    Topics: Adenosine; Adenosine Triphosphate; Adenylate Kinase; Adrenergic beta-Antagonists; Allopurinol; Anima

2010